At the beginning of the week the Government Accountability Office (GAO) issued a report on Round 2 of Competitive Bidding which found that beneficiaries receiving DME covered under competitive bidding. The report found that decreased access came from both Round 2 and National Mail-order supplies. CMS maintains the narrative that there are no patient access issues, yet industry stakeholders and government research shows the complete opposite.
The HME Cost Study, conducted by AAHomecare compliments these findings which shows that these cuts are not sustainable by providers as reimbursements are only covering an average of 88% of the overall costs for providing a single item.
|DMEPOS Product||Median Percent
of Costs Covered
|Heavy Duty Beds||90.35%|
|All Other Oxygen||94.60%|
|BiPAP with Supplies||91.52%|
|CPAP with Supplies||67.83%|
|Lightweight Wheelchairs with Elevating Leg Rests||82.72%|
|Lightweight Wheelchairs with Footrests||82.79%|
|Standard Wheelchairs with Elevating Leg Rests||80.55%|
|Standard Wheelchairs with Footrests||71.35%|
|All Products Overall||87.68%|
For more details, see:
- Executive Summary
- Analysis of the Cost of Providing Durable Medical Equipment to the Medicare Population: Measuring the Impact of Competitive Bidding (full report)